Industry Trends

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More




ISI Streamlines Collaborative Space with SharePoint



By Ann Neuer

April 27, 2009 | Image Solutions (ISI) is bringing greater efficiency to the collaborative document management space with the integration of its Regulatory Solutions Suite with Microsoft Office SharePoint Server 2007. SharePoint Server is Microsoft’s tool for facilitating collaboration and supplying access to data that are essential across the organization.

Toban Zolman, ISI’s director of consulting services, says the integration offers extended functionality and streamlined processes to the growing number of clients who use SharePoint Server. “We’re seeing a trend whereby more life science companies are embracing SharePoint as the go-to platform either for collaboration or as a system to manage documents. This brings our regulatory suite to more of those companies,” he notes.

Toban_Zolman
Toban Zolman
Improving operations within collaborative space is a visible concern for biopharmaceutical sponsors who are outsourcing multiple functions such as R&D; chemistry, manufacturing and control (CMC); clinical trial operations; and regulatory submissions, all in an effort to accelerate timelines and contain costs. To support this effort, they need a resource that speeds the flow of information internally and among external providers who are increasingly involved in all aspects of pre-clinical and clinical development. 

Zolman explains that collaborative efforts with outsourced partners for regulatory purposes have never been greater as regulatory authors and publishers build submissions with input from multiple areas within and outside the organization. “There is another level of abstraction and complication when sponsors are not performing these functions on their own. They may be partnering with other pharma companies, outsourced providers, and leveraging resources from contract research organizations (CROs). So, it isn’t just cross-functional, but cross-organizational,” Zolman says.

The new integration creates a single collaborative space and additional functionality for partners using eCTDXPress and ISIPublisher, ISI’s flagship regulatory products. For starters, clients will be able to leverage metadata that may already exist in SharePoint columns by pulling it in to populate content in the electronic common technical document (eCTD). Specifically, the metadata will help build study tagging files (STFs) and populate leaf titles, basic components of the eCTD. These new functions significantly reduce the amount of manual work that is typically done to complete these tasks.  Before the integration, the publisher had to pull content from a fileshare or from other systems.

There are two options to access the integrated product—a hosted option and a custom installation. According to Zolman, the hosted solution is the more cost-effective choice.  “With the hosted set-up, we have a pre-qualified system, meaning that all of the validation steps have been completed. We create a single virtual environment, execute the installation qualification and operational qualification just once, and then copies of that environment can be deployed again and again to multiple clients without running those scripts each time. This radically reduces the overall validation time and cost associated with each implementation,” Zolman says.

Traditionally, the hosted option has been the choice of smaller companies, with their more limited resources, but that paradigm is changing. Larger customers are now starting to look to hosting and Software as a Service (SaaS) as viable choices instead of their typical penchant for custom installations. Driving the market to the hosted option are the difficulty and cost of maintaining the change control on customized software.

ISI expects the integration of its regulatory suite with SharePoint to be a hit.  Based on first quarter, the company is anticipating a 50 percent increase in SaaS revenues in 2009 as compared to 2008. Looking ahead to 2010, ISI projects a 20 percent growth in SharePoint-related revenues, quarter over quarter. 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 





Sponsored Links

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .